Published in PLoS Genet on September 25, 2014
Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat Neurosci (2016) 0.85
Dynamic DNA Methylation Regulates Levodopa-Induced Dyskinesia. J Neurosci (2016) 0.82
Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network. Cell Rep (2016) 0.78
Transcriptional Response of Polycomb Group Genes to Status Epilepticus in Mice is Modified by Prior Exposure to Epileptic Preconditioning. Front Neurol (2015) 0.78
Transcriptome profiling of the subventricular zone and dentate gyrus in an animal model of Parkinson's disease. Int J Mol Med (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
The human genome browser at UCSC. Genome Res (2002) 168.23
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
Differential expression analysis for sequence count data. Genome Biol (2010) 64.56
Chromatin modifications and their function. Cell (2007) 55.98
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature (2003) 16.48
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
The Polycomb complex PRC2 and its mark in life. Nature (2011) 11.97
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (1990) 8.07
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature (2010) 7.35
Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer (2009) 4.40
The neurobiology of slow synaptic transmission. Science (2001) 3.97
Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell (2013) 3.50
MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol (2002) 3.17
A rapid micro chromatin immunoprecipitation assay (microChIP). Nat Protoc (2008) 3.14
Transcriptional regulation by Polycomb group proteins. Nat Struct Mol Biol (2013) 2.96
DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature (1984) 2.74
Diverse psychotomimetics act through a common signaling pathway. Science (2003) 2.52
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci U S A (2010) 2.36
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J Neurosci (2007) 2.11
Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat Rev Cancer (2010) 1.93
Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation. Mol Cell (2010) 1.84
Npas4 regulates a transcriptional program in CA3 required for contextual memory formation. Science (2011) 1.81
Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice. Proc Natl Acad Sci U S A (2010) 1.74
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiatry (2007) 1.65
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol (2005) 1.65
Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol (1999) 1.60
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc Natl Acad Sci U S A (2014) 1.59
Levodopa motor complications in Parkinson's disease. Trends Neurosci (2000) 1.58
Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol Dis (1999) 1.57
L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. J Neurochem (2009) 1.53
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry (2005) 1.53
The epigenetic landscape of addiction. Ann N Y Acad Sci (2011) 1.51
Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry (2009) 1.44
Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J Neurochem (1999) 1.34
Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J Neurochem (2009) 1.34
Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology (2012) 1.33
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. Front Behav Neurosci (2011) 1.30
Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J Neurosci (2008) 1.27
Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res (2004) 1.22
Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. PLoS One (2010) 1.08
Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain. J Comp Neurol (2004) 1.08
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats. J Neuropathol Exp Neurol (2005) 1.03
D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease. Neuroscientist (2003) 1.00
Galanin and addiction. Cell Mol Life Sci (2008) 1.00
Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat. Neurobiol Dis (2010) 0.98
Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats. Am J Hypertens (1998) 0.97
The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism. Parkinsonism Relat Disord (1998) 0.96
Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission. Brain Res (1999) 0.93
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiol Aging (2011) 0.92
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. Eur J Neurosci (2005) 0.91
Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats. PLoS One (2010) 0.84
Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease. Brain Res Mol Brain Res (2003) 0.81
Extracellular signal-regulated kinases (ERK) and protein kinase C (PKC) activities are involved in the modulation of Nur77 and Nor-1 expression by dopaminergic drugs. J Neurochem (2008) 0.79
Neuropeptide Y-immunoreactive neurons in the striatum of cat and monkey: morphological characteristics, intrinsic organization and co-localization with somatostatin. Brain Res (1986) 0.79
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Prog Neurobiol (2015) 1.13
A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression. Biol Psychiatry (2014) 1.13
Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism. Biol Psychiatry (2013) 0.83
Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nat Biotechnol (2017) 0.81
Somatosensory map expansion and altered processing of tactile inputs in a mouse model of fragile X syndrome. Neurobiol Dis (2016) 0.76
Differential regulation of the phosphorylation of Trimethyl-lysine27 histone H3 at serine 28 in distinct populations of striatal projection neurons. Neuropharmacology (2016) 0.75
An interactive framework for whole-brain maps at cellular resolution. Nat Neurosci (2017) 0.75